Combating antimicrobial resistance: policy recommendations to save lives.
作者：
DOI: 10.1093/CID/CIR153
关键词: Health policy 、 MEDLINE 、 Drug Utilization 、 Antibiotic resistance 、 Biotechnology 、 Medicine 、 Drug resistance
摘要:
oxfordjournals.org
sci-hub.se 参考文章(107)
S. T. Madsen, Scarlet fever and erysipelas in Norway during the last hundred years Infection. ,vol. 1, pp. 76- 81 ,(1973) , 10.1007/BF01638479
Eric P Brass, George H Talbot, John S Bradley, David N Gilbert, Helen W Boucher, Brad Spellberg, Position paper: recommended design features of future clinical trials of antibacterial agents for community-acquired pneumonia. Clinical Infectious Diseases. ,(2008)
Elmore Hathaway Northey, John Thomas Litchfield, Harold James White, The sulfonamides and allied compounds ,(1948)
D. A. Relman, A. Mack, E. R. Choffnes, Antibiotic resistance : implications for global health and novel intervention strategies : workshop summary Antibiotic resistance: implications for global health and novel intervention strategies. Workshop summary.. ,(2010)
C. A. Shull, Praktikum der Zell- und Gewebephysiologie der Pflanze.Siegfried StruggerLaboratory Plant Physiology.B. S. Meyer , D. B. Anderson Botanical Gazette. ,vol. 97, pp. 430- 430 ,(1935) , 10.1086/334577
S.J. Projan, D.M. Shlaes, Antibacterial drug discovery: is it all downhill from here? Clinical Microbiology and Infection. ,vol. 10, pp. 18- 22 ,(2004) , 10.1111/J.1465-0691.2004.1006.X
R Kay, Statistical principles for clinical trials. Journal of International Medical Research. ,vol. 26, pp. 57- 65 ,(1998) , 10.1177/030006059802600201
Graham Worrall, Gregory Sherman, Joseph Griffiths, James Hutchinson, Diagnosing streptococcal sore throat in adults: randomized controlled trial of in-office aids. Canadian Family Physician. ,vol. 53, pp. 666- 671 ,(2007)
Jesús Rodríguez-Baño, Juan C Alcalá, Jose M Cisneros, Fabio Grill, Antonio Oliver, Juan P Horcajada, Teresa Tórtola, Beatriz Mirelis, Gemma Navarro, María Cuenca, María Esteve, Carmen Pena, Ana C Llanos, Rafael Cantón, Alvaro Pascual, None, Community Infections Caused by Extended-Spectrum β-Lactamase–Producing Escherichia coli Archives of Internal Medicine. ,vol. 168, pp. 1897- 1902 ,(2008) , 10.1001/ARCHINTE.168.17.1897
Glenn S. Tillotson, Development of New Antibacterials: A Laudable Aim, But What Is the Value? Clinical Infectious Diseases. ,vol. 51, pp. 752- 753 ,(2010) , 10.1086/655956